下一代神经肿瘤学
神经肿瘤学是介于多个诊断与治疗学科之间的高度专业化多学科领域。原发脑肿瘤的主要挑战是将分子遗传学进展转化为临床获益,中枢神经系统转移的诊断管理需考虑靶向治疗和免疫肿瘤学等新系统治疗选项,这些治疗也带来神经系统毒性问题。以上论据支持在欧洲发展专科卓越中心以改善脑肿瘤患者照护。
要点
- 原发脑肿瘤的核心挑战是将分子遗传学进展转化为患者临床获益。
- 中枢神经系统转移是许多系统癌症日益常见的并发症,需考虑靶向和免疫治疗等新选项。
- 新旧抗癌治疗的神经系统毒性诊断、治疗和预防是神经肿瘤学的重要领域。
核心结论
- 神经肿瘤学需发展专科卓越中心以改善欧洲脑肿瘤患者照护。
主要发现
- 原发脑肿瘤尤其是胶质母细胞瘤的分子遗传学复杂性已有独特进展。
- 中枢神经系统转移在许多系统癌症中日益常见。
- 靶向治疗和免疫肿瘤学等新系统治疗选项影响中枢神经系统转移的管理。
- 新旧抗癌治疗的神经系统毒性是神经肿瘤学的第三大领域。
临床怎么用
- 中枢神经系统转移的诊断和管理需考虑靶向治疗和免疫肿瘤学等新系统治疗选项。
- 应关注新旧抗癌治疗相关的神经系统毒性诊断、治疗和预防。
- 支持发展专科卓越中心以改善脑肿瘤患者照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuro-oncology has evolved as a growing, but still small, highly specialised and multidisciplinary field at the interface of several diagnostic and therapeutic disciplines. The major challenge in the field of primary tumours is to translate the almost unique progress in deciphering the highly complex molecular genetic nature of many primary brain tumours, notably glioblastoma, into advances that allow for clinical benefit for affected patients. Furthermore, metastases to the central nervous system are an increasingly prevalent complication in many systemic cancers. Their diagnosis and management require major expertise, notably with consideration of several new systemic therapy options, such as targeted therapy and immuno-oncology approaches. These new treatments contribute to challenges within the third major domain of neuro-oncology, the diagnosis, treatment and prevention of nervous system toxicity of old and new anti-cancer treatments. All these considerations strongly argue for the development of specialised centres of excellence to improve care for patients with brain tumour across Europe.
引用
- Weller M. Next generation neuro-oncology. Eur J Cancer. 2018. PMID: 29656021. doi:10.1016/j.ejca.2018.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。